« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 3
, Pages 201-207
, September 2008
Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images
References
- . Frontiers in cardiovascular magnetic resonance. Circulation. 2005;112:135–144
- . Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles. Acad Radiol. 2006;13:421–427
- Synthesis of ultrafine Gd2O3 nanoparticles inside single-wall carbon nanohorns. J Phys Chem B. 2006;110:5179–5181
- . Gadolinium-based hybrid nanoparticles as a positive MR contrast agent. J Amer Chem Soc. 2006;128:15090–15091
- . Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent. J Nanosci Nanotechnol. 2006;6:996–1003
- . Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release. 2004;95:613–626
- Gadolinium mixed-micelles: effect of the amphiphile on in vitro and in vivo efficacy in apolipoprotein E knockout mouse models of atherosclerosis. Mag Reson Med. 2006;56:1336–1346
- . Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy. Int J Pharm. 2006;320:96–103
- . Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Del Rev. 2005;57:2271–2286
- . Detection of tumor angiogenesis in vivo by alpha(v)beta(3)-targeted magnetic resonance imaging. Nat Med. 1998;4:623–626
- . Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Lett. 2006;6:1160–1164
- Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe. Cancer Res. 2006;66:9196–9201
- . The chemistry of contrast agents in magnetic resonance imaging. Chichester, UK: Wiley; 2001;
- Biology of TiO2-oligonucleotide nanocomposites. Nat Mater. 2003;2:343–346
- Intracellular localization of titanium dioxide-biomolecule nanocomposites. J Physique Iv. 2003;104:317–319
- Intracellular distribution of TiO(2)-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificity. Nano Lett. 2007;7:596–601
- . X-ray fluorescence microprobe imaging in biology and medicine. J Cell Biochem. 2006;99:1489–1502
- Nanoparticles for applications in cellular imaging. Nanoscale Res Lett. 2007;2:430–441
- . Polypeptides. 18. A kinetic study of the polymerization of amino acid N-carboxyanhydrides initiated by strong bases. J Amer Chem Soc. 1958;80:2387–2393
- . Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging. Mag Reson Imaging. 2006;24:931–940
- . Surface restructuring of nanoparticles: an efficient route for ligand-metal oxide crosstalk. J Phys Chem B. 2002;106:10543–10552
- . The interaction of linear polyphosphates with titanium dioxide surfaces. Phys Chem Chem Phys. 2000;2:2985–2992
- . Data analysis for X-ray fluorescence imaging. J Physique Iv. 2003;104:617–622
- . The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging. 1990;8:467–481
- . Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol. Invest Radiol. 1999;34:126–133
- Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. Cancer Res. 2001;61:4272–4277
This work was supported in part by the following National Institutes of Health grants: CA107467, EB002100, P50 CA89018, U54CA119341; by Department of Energy (DOE) grant FG02-04 ER 63920; and by Siemens Medical Solutions. Use of the Advanced Photon Source was supported by the US DOE, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.
PII: S1549-9634(08)00046-4
doi: 10.1016/j.nano.2008.04.004
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 3
, Pages 201-207
, September 2008
